GlassScriptPhysician profile
Mary Herrera
NPI 1679102347
$2,293.99
in general payments reported to CMS, 2019-2025
16 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $238 · 2022: $309 · 2023: $939 · 2024: $691 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,738 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,738.43 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $756.85 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $290.00 | 2022-2024 | Rexulti, Abilify Maintena, Nuedexta |
| Takeda Pharmaceuticals U.S.A., INC. | $182.14 | 2022-2024 | Trintellix |
| Alkermes, INC. | $151.01 | 2023-2025 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $137.95 | 2022-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $129.08 | 2021-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $128.12 | 2023-2025 | Fanapt, Hetlioz |
| Janssen Pharmaceuticals, INC | $118.41 | 2023-2025 | Spravato |
| Corium, LLC | $83.26 | 2023-2024 | Azstarys |
| Almatica Pharma LLC | $78.31 | 2021-2023 | Gralise |
| Axsome Therapeutics, INC. | $68.30 | 2023-2024 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $67.85 | 2022-2024 | Austedo Xr |
| Lundbeck LLC | $57.85 | 2022-2024 | Rexulti |
| Idorsia Pharmaceuticals US INC | $16.87 | 2023 | Quviviq |
| Neos Therapeutics, LP | $15.20 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $12.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Herrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.